Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services
Seiten
2009
McGraw-Hill Professional (Verlag)
978-0-07-159748-7 (ISBN)
McGraw-Hill Professional (Verlag)
978-0-07-159748-7 (ISBN)
An industry insider shares his strategy for
investing in the high-growth industry of health care
Is your portfolio in peak health?
Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for investment gain.”
Health-Care Investing provides a thorough explanation of how the industry's mammoth size and complexity can be worked to your advantage and why health care is more resistant to changes in economic cycles than other markets. Funtleyder gives you a comprehensive overview of the industry, from both macro and micro points of view, so you can make informed decisions regarding your investments. You'll find critical information concerning
The natural inelasticity of health care and how to profit from itHow to take advantage of the market's complexities and inefficienciesIssues and policy changes you need to know The social responsibility aspect of investing in health careWhy this market is essential for diversified portfolios
In Health-Care Investing, Funtleyder provides the tools you need to dig up the richest opportunities possible and build them into your investment strategy. You'll get a detailed look at traditional market patterns and the events that have shaped--and will continue to shape--the industry. Then you'll find specific strategies you can use to maximize your profits, whether you invest in pharma, biotech, managed services, or a combination of them. This informative and practical guide also includes a list of questions you can use as an investment “template,” which will help guide your decision-making process.
With Health Care Investing, you'll be armed with the know-how to make the right decisions today in order to fully capitalize on events of the future.
investing in the high-growth industry of health care
Is your portfolio in peak health?
Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for investment gain.”
Health-Care Investing provides a thorough explanation of how the industry's mammoth size and complexity can be worked to your advantage and why health care is more resistant to changes in economic cycles than other markets. Funtleyder gives you a comprehensive overview of the industry, from both macro and micro points of view, so you can make informed decisions regarding your investments. You'll find critical information concerning
The natural inelasticity of health care and how to profit from itHow to take advantage of the market's complexities and inefficienciesIssues and policy changes you need to know The social responsibility aspect of investing in health careWhy this market is essential for diversified portfolios
In Health-Care Investing, Funtleyder provides the tools you need to dig up the richest opportunities possible and build them into your investment strategy. You'll get a detailed look at traditional market patterns and the events that have shaped--and will continue to shape--the industry. Then you'll find specific strategies you can use to maximize your profits, whether you invest in pharma, biotech, managed services, or a combination of them. This informative and practical guide also includes a list of questions you can use as an investment “template,” which will help guide your decision-making process.
With Health Care Investing, you'll be armed with the know-how to make the right decisions today in order to fully capitalize on events of the future.
Les Funtleyder serves as healthcare strategist for Miller Tabak + Co. He previously managed the health-care portfolio of the Minneapolis-based hedge fund Provident Advisors. Funtleyder makes frequent appearances on CNBC, Bloomberg, and National Public Radio.
Introduction
Healthcare State of the Union
Issues, Policies, Market Movement
Participants
The 14 Questions That Guide Investment
Judging Potential Investments
Picking Stocks
Pharmaceuticals
Biotechnology
Managed Care
Medical Technology
Services
Other Health Care Companies
Conclusion
| Erscheint lt. Verlag | 16.2.2009 |
|---|---|
| Zusatzinfo | 10 Illustrations |
| Sprache | englisch |
| Maße | 160 x 234 mm |
| Gewicht | 553 g |
| Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
| Medizin / Pharmazie ► Pharmazie | |
| Technik ► Umwelttechnik / Biotechnologie | |
| Wirtschaft ► Betriebswirtschaft / Management ► Finanzierung | |
| Schlagworte | Biotechnologie-Unternehmen • Kapitalanlage • Pharmazeutische Unternehmen |
| ISBN-10 | 0-07-159748-4 / 0071597484 |
| ISBN-13 | 978-0-07-159748-7 / 9780071597487 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Allgemeines Steuerrecht, Abgabenordnung, Umsatzsteuer
Buch (2024)
Springer Gabler (Verlag)
CHF 39,20
Band 1: Grundlagen der Besteuerung, Ertragsteuern
Buch | Softcover (2024)
Vahlen (Verlag)
CHF 41,70
Investition, Finanzierung, Finanzmärkte und Steuerung
Buch | Softcover (2022)
Vahlen (Verlag)
CHF 55,70
